JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patel, V.
Right arrow Articles by Connolly, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, V.
Right arrow Articles by Connolly, C.
Journal of Neurology Neurosurgery and Psychiatry 2002;73:598-599
© 2002 Journal of Neurology Neurosurgery and Psychiatry


LETTER

Cytokine profiles in HIV seropositive patients with tuberculous meningitis

VB Patel1, AI Bhigjee1, PLA Bill1, CA Connolly2

1 Division of Neurology, Nelson R Mandela School of Medicine, University of Natal, Durban, South Africa
2 Biostatistics, Medical Research Council, Durban, South Africa

Correspondence to:
Correspondence to:
Dr VB Patel, Department of Neurology, Ward A3, Wentworth Hospital, Private Bag Jacobs, Durban 4026, South Africa;
patelv@nu.ac.za

Keywords: human immunodeficiency virus; cytokines; tuberculous meningitis

The first 150 words of the full text of this article appear below.

The immunological response in pulmonary and pleural tuberculosis has been extensively studied. However, the response in tuberculous meningitis has not been well documented.1 In pulmonary disease, exposure to tuberculous antigens results in a T cell and natural killer cellular response, elaborating various cytokines, mainly of T helper type 1 (Th1) origin. Stimulated macrophages elaborate tumour necrosis factor (TNF) {alpha}, interleukin (IL) 12, and IL 1, promoting further recruitment and activation of macrophages and lymphocytes.

TNF {alpha} correlates with disease severity and may contribute to tissue necrosis; however, TNF{alpha} has also contributed to survival in mouse studies.2 Transforming growth factor ß (Th3 cytokine) suppresses macrophage activation. IL 2 may be beneficial in promoting an immune response in HIV seropositive patients. Th1 and Th2 cytokine responses have been observed in cerebrospinal fluid (CSF) of HIV seronegative patients with tuberculous meningitis.3,4. Whether the response is similar in HIV seropositive patients with tuberculous meningitis . . . [Full text of this article]




This article has been cited by other articles:


Home page
Sex. Transm. Infect.Home page
V. Patel, A. Bhigjee, P. Bill, and C. Connolly
Cytokine profiles in HIV seropositive patients with tuberculous meningitis
Sex. Transm. Inf., February 1, 2003; 79(1): 75 - 76.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 by the BMJ Publishing Group Ltd.